— Tandem Diabetes (NASDAQ: TNDM) reported earnings of $0.04 per share in the fourth quarter of 2019, vs $0.05 per share loss expected
— Q4 Sales grew 42% to $108.4 million, vs. $109.2 million expected
— Worldwide pump shipments increased 21% to 19,602 pumps in Q4
— For FY20, sales are estimated to be in the range of $450 million to $465 million, up 24% to 28%. Adjusted EBITDA is estimated to be 12% to 14%
— TNDM fell 3.8% immediately following the announcement.
Most Popular
360 DigiTech (NASDAQ: QFIN) Q2 2021 Research Summary
The pandemic-induced financial uncertainties have changed the dynamics of the consumer lending market. Customers are being drawn to online lending platforms that provide easy access to credit on convenient terms
Banxa founder Domenic Carosa: Crypto industry seeing huge HNI interest
While bitcoin and other digital currencies have seen a fair share of ups and downs so far this year, investor interest in cryptocurrency has grown undeniably during this period. The
Oracle (ORCL) Q4 earnings, revenue beat Street view
Software giant Oracle Corporation (NYSE: ORCL) reported a 28% growth in fourth-quarter earnings, aided by an increase in revenues. The results also topped Wall Street's prediction. At $11.2 billion, revenues
